Global Health Trends And Pipeline Launches Will Fuel Future Potential

Published
22 Mar 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$12.00
21.7% undervalued intrinsic discount
08 Aug
US$9.40
Loading
1Y
20.4%
7D
16.8%

Author's Valuation

US$12.0

21.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 1.69%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 1.29%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.85%

AnalystConsensusTarget has decreased profit margin from 4.8% to 3.1%, increased future PE multiple from 26.9x to 41.4x and decreased shares outstanding growth rate from 0.0% to 0.0%.

Shared on02 Apr 25
Fair value Increased 2.44%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.